Show simple item record

dc.contributor.authorFarreny, Aen_US
dc.contributor.authorSavill, Men_US
dc.contributor.authorPriebe, Sen_US
dc.date.accessioned2017-08-03T08:34:54Z
dc.date.available2017-05-25en_US
dc.date.issued2018-09en_US
dc.date.submitted2017-07-28T15:30:04.287Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/25051
dc.description.abstractThere has been a debate in the literature about the distinction between primary and secondary negative symptoms of schizophrenia. Our aim was to study the associations between negative symptoms and potential sources of secondary negative symptoms over time. A sample of 275 participants with at least mid-moderate negative symptoms was randomized into body psychotherapy or Pilates class in a previous study. No significant differences were found between groups over time and changes in the symptom domains were modest. The present investigation considers the longitudinal correlation between variables of interest at baseline, 3 and 9 months follow-up. Measures were the Clinical Assessment Interview for Negative Symptoms (CAINS), the Positive and Negative Symptom Scale (PANSS), the Calgary Depression Scale (CDSS) and the Simpson-Angus Extrapyramidal side-effects Scale (SAS). Mixed models were computed to test the longitudinal association between these variables. In a sensitivity analysis, the dosages of antipsychotic, illness duration and allocated intervention were taken into account. Overall, the course of extrapyramidal side-effects, depressive and positive symptoms was significantly related to the course of negative symptoms. Only extrapyramidal effects were longitudinally correlated to expressive negative symptoms. The sensitivity analyses showed unaltered results for positive symptoms and depression but a lack of association between extrapyramidal effects and the CAINS outcomes. In conclusion, the unambiguous interpretation between primary and secondary negative symptoms may lead to refined treatment approaches for schizophrenia and to increased effects of the interventions.en_US
dc.description.sponsorshipThe data was collected as part of the NESS study, a trial funded by a grant from the National Institute for Health Research-Health Technology Assessment programme (REF: 08/116/68). The funding source had no role in the present study design, analysis, interpretation or manuscript submission.en_US
dc.format.extent603 - 609en_US
dc.languageengen_US
dc.relation.ispartofEur Arch Psychiatry Clin Neuroscien_US
dc.rightsThe final publication is available at Springer via http://dx.doi.org/10.1007/s00406-017-0813-y
dc.subjectCAINSen_US
dc.subjectDepressionen_US
dc.subjectExtrapyramidal effectsen_US
dc.subjectPositive symptomsen_US
dc.subjectPrimary negative symptomsen_US
dc.subjectSchizophreniaen_US
dc.subjectAdulten_US
dc.subjectAgeden_US
dc.subjectAkathisia, Drug-Induceden_US
dc.subjectAntipsychotic Agentsen_US
dc.subjectCombined Modality Therapyen_US
dc.subjectDepressionen_US
dc.subjectDyskinesia, Drug-Induceden_US
dc.subjectExercise Movement Techniquesen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectLongitudinal Studiesen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectOutcome Assessment, Health Careen_US
dc.subjectPsychotherapyen_US
dc.subjectSchizophreniaen_US
dc.subjectYoung Adulten_US
dc.titleCorrespondence between negative symptoms and potential sources of secondary negative symptoms over time.en_US
dc.typeArticle
dc.rights.holder© Springer-Verlag Berlin Heidelberg 2017
dc.identifier.doi10.1007/s00406-017-0813-yen_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/28577223en_US
pubs.issue6en_US
pubs.notesNo embargoen_US
pubs.notesBackground: There has been a debate in the literature about the distinction between primary and secondary negative symptoms of schizophrenia. The aim was to study the associations between negative symptoms and potential sources of secondary negative symptoms over time. Methods: A sample of 275 participants with at least mid-moderate negative symptoms was randomized into body psychotherapy or Pilates class in a previous study. No significant differences were reported between groups over time and changes in the symptom domains were modest. The present investigation considers the longitudinal correlation between variables of interest at baseline, 3 months and 9 months follow-up. Measures were the Clinical Assessment Interview for Negative Symptoms (CAINS), the Positive and Negative Symptom Scale (PANSS), the Calgary Depression Scale (CDSS) and the Simpson-Angus Extrapyramidal side-effects Scale (SAS). Mixed models were computed to test the longitudinal association between these variables. In a sensitivity analysis, the dosages of antipsychotic, illness duration and allocated intervention were taken into account. Results: Overall, the course of extrapyramidal side-effects, depressive and positive symptoms was significantly related to the course of negative symptoms. Only extrapyramidal effects were longitudinally correlated to expressive negative symptoms. The sensitivity analyses showed a lack of association between extrapyramidal effects and the CAINS outcomes. Conclusions: The unambiguous interpretation between primary and secondary negative symptoms may lead to refined treatment approaches for schizophrenia and to increased effects of the interventions. Keywords: Schizophrenia, Primary negative symptoms, Depression, Positive symptoms, Extrapyramidal effects, CAINSen_US
pubs.publication-statusPublisheden_US
pubs.volume268en_US
dcterms.dateAccepted2017-05-25en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record